Union Korea Pharm Co., Ltd. (KOSDAQ:080720)
South Korea · Delayed Price · Currency is KRW 2,725.00
-310.00 (-10.21%)
At close: Oct 11, 2024
Union Korea Pharm Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -30,544 | -30,820 | -20,916 | -18,156 | -932.02 | -11,109 |
Depreciation & Amortization | 1,648 | 1,803 | 2,877 | 3,890 | 3,994 | 4,226 |
Loss (Gain) From Sale of Assets | -86.59 | -35.25 | -0.67 | -129.04 | - | -7.54 |
Asset Writedown & Restructuring Costs | 5,654 | 5,654 | 5,160 | 9,449 | - | 1,547 |
Loss (Gain) From Sale of Investments | - | - | - | - | - | -0.38 |
Loss (Gain) on Equity Investments | 495.52 | 518.08 | 23.89 | 19.46 | 5.47 | 9.88 |
Provision & Write-off of Bad Debts | 7,741 | 7,458 | -2,353 | -920.95 | -1,942 | -1,882 |
Other Operating Activities | 14,456 | 14,544 | 4,260 | 5,056 | 2,525 | 4,199 |
Change in Accounts Receivable | 3,267 | 3,987 | 16,592 | 373.21 | -4,996 | 1,288 |
Change in Inventory | -409.86 | 1,487 | -6,941 | 3,542 | -1,651 | 364.26 |
Change in Accounts Payable | -2,628 | -3,349 | 3,642 | -1,373 | -795.59 | 3,151 |
Change in Other Net Operating Assets | -3,005 | -2,381 | -1,922 | -387.99 | -1,271 | 128.6 |
Operating Cash Flow | -3,412 | -1,134 | 420.21 | 1,362 | -5,063 | 1,915 |
Operating Cash Flow Growth | - | - | -69.15% | - | - | - |
Capital Expenditures | -130.74 | -95.74 | -949.44 | -2,263 | -3,366 | -7,168 |
Sale of Property, Plant & Equipment | 100.81 | 48.99 | - | 10.27 | - | 23.44 |
Cash Acquisitions | - | - | - | -111.04 | - | - |
Sale (Purchase) of Intangibles | 6.09 | -6.41 | -5.3 | 206.04 | -89 | -100 |
Investment in Securities | 1,468 | 1,181 | 128.33 | 49.99 | -72.81 | -828.4 |
Other Investing Activities | - | - | - | -0 | - | 0 |
Investing Cash Flow | 1,444 | 1,128 | -826.41 | -2,108 | -3,528 | -8,073 |
Short-Term Debt Issued | - | - | 3,000 | 15,332 | 3,500 | 3,000 |
Long-Term Debt Issued | - | - | 3,000 | 20,846 | - | 29,697 |
Total Debt Issued | 2,000 | - | 6,000 | 36,178 | 3,500 | 32,697 |
Short-Term Debt Repaid | - | -800 | -6,200 | -3,095 | -4,000 | -2,300 |
Long-Term Debt Repaid | - | -386.61 | -1,676 | -31,823 | -1,579 | -564.26 |
Total Debt Repaid | -804.43 | -1,187 | -7,876 | -34,919 | -5,579 | -2,864 |
Net Debt Issued (Repaid) | 1,196 | -1,187 | -1,876 | 1,260 | -2,079 | 29,833 |
Issuance of Common Stock | - | - | - | 28.37 | - | - |
Repurchase of Common Stock | - | - | - | - | -2,717 | -4,592 |
Other Financing Activities | -0 | -0 | - | 50 | -1,229 | -0 |
Financing Cash Flow | 1,196 | -1,187 | -1,876 | 1,338 | -6,025 | 25,241 |
Foreign Exchange Rate Adjustments | 9.86 | -7.57 | 27.56 | -25.56 | -31.68 | 19.07 |
Net Cash Flow | -762.85 | -1,200 | -2,254 | 566.84 | -14,647 | 19,101 |
Free Cash Flow | -3,543 | -1,230 | -529.23 | -901.15 | -8,429 | -5,254 |
Free Cash Flow Margin | -11.95% | -3.38% | -1.03% | -1.43% | -13.75% | -10.88% |
Free Cash Flow Per Share | -490.11 | -170.11 | -73.22 | -124.80 | -1142.33 | -676.09 |
Cash Interest Paid | - | 507.14 | 901.99 | 621.78 | 595.25 | 448.98 |
Cash Income Tax Paid | - | -7.77 | -1.3 | 7.23 | -2.49 | -706.96 |
Levered Free Cash Flow | 23,203 | 6,913 | 13,375 | -7,528 | -13,368 | 7,871 |
Unlevered Free Cash Flow | 25,371 | 8,939 | 15,825 | -4,958 | -11,591 | 9,264 |
Change in Working Capital | -2,776 | -256.12 | 11,370 | 2,154 | -8,713 | 4,932 |